Califf: More Expedited Approvals Mean US Clearance Only The Beginning Of Learning About Medical Products

The US FDA commissioner said increased use of expedited approval pathways will help spur clinical research system reform.

Califf speaks to DIA
FDA Commissioner Robert Califf spoke at the DIA Global Annual Meeting in Chicago via video. • Source: Derrick Gingery

More from Clinical Trials

More from R&D